Ipratropium: Clinical Trials

83 trials of Ipratropium, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

66 completed, 10 unknown, 4 terminated, 2 not yet recruiting. 24 Phase 4, 17 Phase 3, 16 Not applicable, 14 Phase 2, 6 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 424Completed 20, Terminated 2, Not yet recruiting 1, Unknown 1
Phase 317Completed 12, Unknown 3, Terminated 1, Withdrawn 1
Not applicable16Completed 10, Unknown 5, Terminated 1
Phase 214Completed 11, Unknown 2, Not yet recruiting 1
Phase 16Completed 6
Early Phase 11Completed 1

Follow Ipratropium: new trials by email Literature Review of Ipratropium trials Research Report on Ipratropium

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of Nebulized Long-Acting Bronchodilators (Formoterol and Revefenacin) vs. Short-Acting Bronchodilators (Albuterol and Ipratropium) in Patients Presenting to the Emergency Department With Acute Exacerbation of COPD (ECOPD)
Revefenacin, formoterol fumarate, Placebo (Sterile Normal Saline) - COPD Exacerbation
Phase 4Not yet recruitingUniversity of Tennessee Graduate School of Medicine2802026-11-122026-10-19
Effect of Ipratropium Bromide on EILO
Ipratropium Bromide, Normal Saline (Placebo) - Exercise-Induced Laryngeal Obstruction, Dyspnea During Activity
Phase 2Not yet recruitingCook Children's Health Care System502026-06-012026-05-05
A Combination of an Inhaled Budesonide and Ipratropium in Patients at Risk of Developing ARDS
combined standard aerosolized doses of budesonide (0.5 mg/2 mL) every 12 hours and ipratropium bromide (500/2 mL) every eight hours for up to five days, Placebo - ARDS, Prevention and Control
Phase 1 / Phase 2CompletedDamanhour University1192024-05-012025-02-06
A RCT to Compare the Effectiveness of Nebulized Anticholinergics for Cough Suppression During Flexible Bronchoscopy
Glycopyrronium, Ipratropium, Saline - Subjects Undergoing Flexible Bronchoscopy
Phase 2 / Phase 3UnknownPost Graduate Institute of Medical Education and Research, Chandigarh10502024-04-242024-04-22
Role of Parasympathetic Activity in Mild to Severe Asthma With Fixed Airway Obstruction (PARASMA Study)
Salbutamol, Ipratropium Bromide, Salbutamol plus Ipratropium Bromide - Asthma, Airway Obstruction
Not applicableUnknownHat Yai Medical Education Center602024-02-172024-02-20
Treating Respiratory Emergencies in Children Study
Ipratropium Bromide - Asthma in Children
Phase 2CompletedOregon Health and Science University442024-01-192026-04-24
A Comparative Study of Adding Ipratropium to Salbutamol for the Treatment of Asthma Attack in Children
Salbutamol (Ventolin®), salbutamol + ipratropium bromide nebules - Asthma Exacerbation, Children
Phase 4CompletedChildren's Hospital and Institute of Child Health, Multan602024-01-012025-04-09
Comparison of Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination in pMDI Form in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients
Ipratropium / Levosalbutamol Fixed Dose Combination, Ipratropium + Levosalbutamol Free Dose Combination - COPD
Phase 3UnknownNeutec Ar-Ge San ve Tic A.Ş742023-09-282023-10-03
Comparison of Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination Nebuliser Solutions in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients
Ipratropium / Levosalbutamol Fixed Dose Combination, Ipratropium + Levosalbutamol Free Dose Combination - COPD
Phase 3UnknownNeutec Ar-Ge San ve Tic A.Ş742023-08-252023-09-05
Neural Respiratory Drive of Patients With Chronic Obstructive Pulmonary Disease
compound ipratropium bromide solution (3mg salbutamol and 500μg ipratropium, Boehringer Ingelheim Limited, Germany) - Chronic Obstructive Pulmonary Disease
Not applicableCompletedThe First Affiliated Hospital of Guangzhou Medical University442023-01-012025-05-07
Bronchodilators on the Exercise Capacity of Bronchiectasis Patients
Bronchodilator (Ipratropium and Fenoterol), Placebo - Bronchiectasis Adult
Not applicableUnknownUniversity of Sao Paulo General Hospital402022-04-142023-12-11
Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPD
Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination (2 inhalations) via pMDI, Salbutamol 100 mcg Inhaler (2 inhalations) + Ipratropium 20 mcg Inhalation Aerosol (2 inhalations) Free Combination via MDI - Chronic Obstructive Pulmonary Disease
Phase 3WithdrawnNeutec Ar-Ge San ve Tic A.Ş2021-09-032021-09-13
Revefenacin in Acute Respiratory Insufficiency in COPD
Revefenacin Inhalation Solution [Yupelri], Ipratropium Bromide - COPD, Acute Respiratory Failure
Phase 2CompletedUniversity of California, Los Angeles212020-11-012026-10-14
Ipratropium Bromide Spray as Treatment for Sialorrhea in Children
Ipratropium bromide, Placebo - Sialorrhea
Phase 2UnknownLondon Health Sciences Centre302019-01-012018-11-21
Non-invasive Ventilation vs. Standard Therapy for Children Hospitalized With an Acute Exacerbation of Asthma
BiPAP, CPAP, Ipratropium - Asthma Acute, Asthma in Children
Not applicableUnknownUniversity of British Columbia1002018-06-012018-05-02
Cryobiopsy Study to Assess Drug Distribution in Subjects With Suspected Interstitial Lung Disease
Ipratropium Bromide, Flexible Bronchoscopy/Biopsy - Lung Diseases, Interstitial
CompletedGlaxoSmithKline82017-11-212019-01-29
Nebulizer Versus Dry Powdered Inhalers for Chronic Obstructive Pulmonary Disease (COPD)
Nebulizers, Dry Powder Inhaler, Brovana - COPD, COPD Exacerbation
Phase 4TerminatedWake Forest University Health Sciences402017-10-032021-06-22
Glittre ADL-test: Responsiveness to Acute Bronchodilation in Chronic Obstructive Pulmonary Disease (COPD)
Bronchodilators, Placebos - Chronic Obstructive Pulmonary Disease
Not applicableUnknownLaval University342017-04-132018-07-06
Influence of Mechanical Ventilation Modes on the Efficacy of Nebulized Bronchodilator
salbutamol sulfate and ipratropium bromide, Mesh nebulization - COPD, Asthma
Not applicableUnknownUniversidade Federal do Rio Grande do Norte102017-04-102019-05-21
Acute Bronchodilator Effect of Inhaled Albuterol Sulfate and Ipratropium Bromide in Patients With Stable COPD
Albuterol Sulfate and Ipratropium Bromide, Albuterol Sulfate - COPD
Phase 1CompletedPneuma Respiratory, Inc462016-12-272018-03-29

Showing 20 of 83. Sign in to see all of them.

Conditions studied

Pulmonary Disease, Chronic Obstructive (46)  ·  Asthma (16)  ·  Dyspnea (3)  ·  Motor Activity (3)  ·  Sialorrhea (3)  ·  Common Cold (2)  ·  Emergencies (2)  ·  Lung Diseases, Obstructive (2)  ·  Acute Lung Injury (1)  ·  Airway Obstruction (1)  ·  Airway Remodeling (1)  ·  Asthma, Exercise-Induced (1)  ·  Autonomic Nervous System Diseases (1)  ·  Bronchiectasis (1)  ·  Bronchiolitis Obliterans Syndrome (1)

Sponsors

Boehringer Ingelheim (19)  ·  GlaxoSmithKline (8)  ·  Neutec Ar-Ge San ve Tic A.Ş (3)  ·  Laval University (2)  ·  AstraZeneca (1)  ·  Beaumont Hospital (1)  ·  Centre for Addiction and Mental Health (1)  ·  Children's Hospital and Institute of Child Health, Multan (1)  ·  Children's Hospital of Philadelphia (1)  ·  Columbia University (1)  ·  Cook Children's Health Care System (1)  ·  Damanhour University (1)  ·  Dey (1)  ·  Fahim Khorfan, MD (1)  ·  Hat Yai Medical Education Center (1)

Countries

United States (25)  ·  United Kingdom (8)  ·  Canada (6)  ·  China (4)  ·  Brazil (2)  ·  Netherlands (2)  ·  Turkey (Türkiye) (2)  ·  Argentina (1)  ·  Australia (1)  ·  Belgium (1)  ·  Egypt (1)  ·  France (1)  ·  India (1)  ·  Ireland (1)  ·  Lithuania (1)

Top investigators

Ahmet Tutuncu, M.D., Ph.D. (1)  ·  Alan James, MBBS (1)  ·  Alvin Ing, MBBS (1)  ·  Ann M. Spungen, EdD (1)  ·  Bryan D. Upham, M.D. (1)  ·  Celso RF Carvalho, PhD (1)  ·  Chen Xin, Doctor (1)  ·  Chris Steinfort, MBBS (1)  ·  Christoph Ellenberger, MD (1)  ·  Colin Reisner, M.D. (1)  ·  Cynthia J Mollen, M.D. (1)

Results publications

PMID 11113831, PMID 11825832, PMID 17890476, PMID 17989152, PMID 19232039, PMID 19496252, PMID 19758522, PMID 21960699, PMID 22509905, PMID 23658479, PMID 25197005, PMID 26024688, PMID 27486205, PMID 29506504, PMID 29631575, PMID 30166326, PMID 33124005, PMID 35546672, PMID 36699648, PMID 40720815, PMID 41943480

NIH funding

2015 (1), UL1TR001412 (1)